An urgent call to increase access to evidence-based opioid agonist therapy for prescription opioid use disorders
- PMID: 27821463
- PMCID: PMC5135485
- DOI: 10.1503/cmaj.160554
An urgent call to increase access to evidence-based opioid agonist therapy for prescription opioid use disorders
Comment on
-
Effective Canadian policy to reduce harms from prescription opioids: learning from past failures.CMAJ. 2016 Dec 6;188(17-18):1240-1244. doi: 10.1503/cmaj.160356. Epub 2016 Nov 7. CMAJ. 2016. PMID: 27821465 Free PMC article. No abstract available.
References
-
- Fischer B, Argento E. Prescription opioid related misuse, harms and interventions in Canada: a review. Pain Physician 2012;15(Suppl 3):ES191–203. - PubMed
-
- Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health 2015;36:559–74. - PubMed
-
- Luce J, Strike C. A cross-Canada scan of methadone maintenance treatment policy developments: a report prepared for the Canadian Executive Council on Addictions. Ottawa: Canadian Executive Council on Addictions; 2011.
-
- Connery HS. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. Harv Rev Psychiatry 2015;23:63–75. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous